Does IRBESARTAN Cause Dyspnoea? 391 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 391 reports of Dyspnoea have been filed in association with IRBESARTAN (Irbesartan). This represents 3.9% of all adverse event reports for IRBESARTAN.
391
Reports of Dyspnoea with IRBESARTAN
3.9%
of all IRBESARTAN reports
13
Deaths
202
Hospitalizations
How Dangerous Is Dyspnoea From IRBESARTAN?
Of the 391 reports, 13 (3.3%) resulted in death, 202 (51.7%) required hospitalization, and 55 (14.1%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 391 reports have been filed with the FAERS database.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Hyponatraemia (485)
Fatigue (483)
Blood pressure increased (477)
Hyperkalaemia (454)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which IRBESARTAN Alternatives Have Lower Dyspnoea Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE